TERF2IP and cancer: Notably, TERF2IP expression is increased in d-flow regions of atherosclerotic plaques and has been linked to various cancers, such as breast cancers, gastric carcinoma, non-small cell lung cancer, and mantle cell lymphoma (106, 382–384).